+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Autoimmune Disease Diagnostics Market Research Report by Type, Indication, Test, Product, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 258 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5014101
UP TO OFF until Dec 31st 2022
The Global Autoimmune Disease Diagnostics Market size was estimated at USD 4,294.85 million in 2021, USD 4,672.36 million in 2022, and is projected to grow at a CAGR of 8.91% to reach USD 7,169.73 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Autoimmune Disease Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Localized Autoimmune Disease Diagnostics and Systemic Autoimmune Disease Diagnostics.
  • Based on Indication, the market was studied across Addison Disease, Celiac Disease, Dermatomyositis, Graves Disease, Hashimoto Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Reactive Arthritis, Rheumatoid Arthritis, Sjögren syndrome, Systemic Lupus Erythematosus, and Type I Diabetes.
  • Based on Test, the market was studied across Autoantibodies & Immunologic Test, Inflammatory Marker, and Routine Laboratory Test. The Autoantibodies & Immunologic Test is further studied across Anti-cyclic Citrullinated Peptide, Antinuclear Antibody, C-reactive Protein, Erythrocyte Sedimentation Rate, Rheumatoid Factor, and Thyroid Antibody Tests. The Thyroid Antibody Tests is further studied across T3, T3RU, T4, and TSH.
  • Based on Product, the market was studied across Consumable & Assay Kit and Diagnostic Instrument.
  • Based on End User, the market was studied across Clinical Laboratory and Hospital.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Autoimmune Disease Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Autoimmune Disease Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Autoimmune Disease Diagnostics Market, including Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Autoimmune Disease Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Autoimmune Disease Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Autoimmune Disease Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Autoimmune Disease Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Autoimmune Disease Diagnostics Market?
6. What is the market share of the leading vendors in the Global Autoimmune Disease Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Autoimmune Disease Diagnostics Market?
Frequently Asked Questions about the Global Autoimmune Disease Diagnostics Market

What is the estimated value of the Global Autoimmune Disease Diagnostics Market?

The Global Autoimmune Disease Diagnostics Market was estimated to be valued at $4294.85 Million in 2021.

What is the growth rate of the Global Autoimmune Disease Diagnostics Market?

The growth rate of the Global Autoimmune Disease Diagnostics Market is 8.9%, with an estimated value of $7169.73 Million by 2027.

What is the forecasted size of the Global Autoimmune Disease Diagnostics Market?

The Global Autoimmune Disease Diagnostics Market is estimated to be worth $7169.73 Million by 2027.

Who are the key companies in the Global Autoimmune Disease Diagnostics Market?

Key companies in the Global Autoimmune Disease Diagnostics Market include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio, Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited and EUROIMMUN Medical Laboratory Diagnostics AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
5.1.1.3. Improved Laboratory Techniques and Automation
5.1.2. Restraints
5.1.2.1. High Frequency of False Positive Results
5.1.2.2. Slow Turnaround Time for Diagnostic Test
5.1.3. Opportunities
5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
5.1.4. Challenges
5.1.4.1. Cost associated with the diagnosis process
5.2. Cumulative Impact of COVID-19
6. Autoimmune Disease Diagnostics Market, by Type
6.1. Introduction
6.2. Localized Autoimmune Disease Diagnostics
6.3. Systemic Autoimmune Disease Diagnostics
7. Autoimmune Disease Diagnostics Market, by Indication
7.1. Introduction
7.2. Addison Disease
7.3. Celiac Disease
7.4. Dermatomyositis
7.5. Graves Disease
7.6. Hashimoto Thyroiditis
7.7. Multiple Sclerosis
7.8. Myasthenia Gravis
7.9. Pernicious Anemia
7.10. Reactive Arthritis
7.11. Rheumatoid Arthritis
7.12. Sjögren syndrome
7.13. Systemic Lupus Erythematosus
7.14. Type I Diabetes
8. Autoimmune Disease Diagnostics Market, by Test
8.1. Introduction
8.2. Autoantibodies & Immunologic Test
8.3.1. Anti-cyclic Citrullinated Peptide
8.3.2. Antinuclear Antibody
8.3.3. C-reactive Protein
8.3.4. Erythrocyte Sedimentation Rate
8.3.5. Rheumatoid Factor
8.3.6. Thyroid Antibody Tests
8.3.7.1. T3
8.3.7.2. T3RU
8.3.7.3. T4
8.3.7.4. TSH
8.3. Inflammatory Marker
8.4. Routine Laboratory Test
9. Autoimmune Disease Diagnostics Market, by Product
9.1. Introduction
9.2. Consumable & Assay Kit
9.3. Diagnostic Instrument
10. Autoimmune Disease Diagnostics Market, by End User
10.1. Introduction
10.2. Clinical Laboratory
10.3. Hospital
11. Americas Autoimmune Disease Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Autoimmune Disease Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. AESKU.GROUP GmbH & Co. KG
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. AstraZeneca PLC
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Beckman Coulter, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Bio-Rad Laboratories, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. BioAgilytix Labs
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Biogenuix Medsystems Private Limited
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. bioMerieux SA
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. EUROIMMUN Medical Laboratory Diagnostics AG
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Exagen Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. F. Hoffmann-La Roche AG
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Hemagen Diagnostics, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Novartis AG
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Pfizer Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Quest Diagnostics
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Sanofi S.A.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. SD BioSensor Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Siemens Healthineers AG
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. SQI Diagnostics
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Thermo Fisher Scientific Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Trinity Biotech PLC
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Werfen Group
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2027
FIGURE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJÖGREN SYNDROME, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2021 VS 2027 (%)
FIGURE 33. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST, 2027
FIGURE 35. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, 2018-2027 (USD MILLION)
FIGURE 43. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, 2018-2027 (USD MILLION)
FIGURE 44. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, 2018-2027 (USD MILLION)
FIGURE 45. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, 2018-2027 (USD MILLION)
FIGURE 47. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, 2018-2027 (USD MILLION)
FIGURE 48. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 49. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 50. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 51. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, 2018-2027 (USD MILLION)
FIGURE 52. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, 2018-2027 (USD MILLION)
FIGURE 53. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 54. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 55. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 56. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, 2018-2027 (USD MILLION)
FIGURE 57. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
FIGURE 58. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 60. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 61. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 62. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 68. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 69. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 70. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 72. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 73. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 74. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 89. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 90. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 96. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 97. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 98. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 99. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 100. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 101. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 102. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 103. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 104. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 105. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 106. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 107. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 108. TURKEY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 109. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 110. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 111. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 112. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 113. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJÖGREN SYNDROME, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJÖGREN SYNDROME, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJÖGREN SYNDROME, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, 2018-2027 (USD MILLION)
TABLE 67. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2027 (USD MILLION)
TABLE 68. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2027 (USD MILLION)
TABLE 69. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2027 (USD MILLION)
TABLE 73. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 74. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 75. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, 2018-2027 (USD MILLION)
TABLE 76. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, BY REGION, 2018-2027 (USD MILLION)
TABLE 77. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, BY REGION, 2018-2027 (USD MILLION)
TABLE 78. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, 2018-2027 (USD MILLION)
TABLE 79. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, BY REGION, 2018-2027 (USD MILLION)
TABLE 80. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, BY REGION, 2018-2027 (USD MILLION)
TABLE 81. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, 2018-2027 (USD MILLION)
TABLE 82. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, BY REGION, 2018-2027 (USD MILLION)
TABLE 83. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, BY REGION, 2018-2027 (USD MILLION)
TABLE 84. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, 2018-2027 (USD MILLION)
TABLE 85. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, BY REGION, 2018-2027 (USD MILLION)
TABLE 86. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, BY REGION, 2018-2027 (USD MILLION)
TABLE 87. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, 2018-2027 (USD MILLION)
TABLE 88. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, BY REGION, 2018-2027 (USD MILLION)
TABLE 89. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, BY REGION, 2018-2027 (USD MILLION)
TABLE 90. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, 2018-2027 (USD MILLION)
TABLE 91. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 92. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 93. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 94. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, 2018-2027 (USD MILLION)
TABLE 95. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 96. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 97. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, 2018-2027 (USD MILLION)
TABLE 98. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 99. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 100. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 101. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, 2018-2027 (USD MILLION)
TABLE 102. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2027 (USD MILLION)
TABLE 103. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2027 (USD MILLION)
TABLE 104. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
TABLE 105. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 106. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 107. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 109. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 110. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 111. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 112. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 113. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 114. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 116. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 117. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 118. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 119. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 120. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 122. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 123. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 124. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 125. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 126. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 128. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 129. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 130. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 131. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 132. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 134. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 135. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 136. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 137. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 138. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 140. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 141. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 142. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 143. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 144. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 145. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 146. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 147. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 148. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 149. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 150. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 151. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 152. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 154. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 155. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 156. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 157. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 158. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 159. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 160. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 161. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 162. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 163. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 164. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 166. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 167. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 168. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 169. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 170. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 171. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 172. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 173. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 174. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 175. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 176. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 178. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 179. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 180. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 181. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 182. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 183. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 184. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 185. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 186. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 187. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 188. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 190. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 191. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 192. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 193. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 194. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 195. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 196. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 197. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 198. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 199. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 200. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 202. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 203. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 204. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 205. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 206. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 207. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 208. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 209. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 210. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 211. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 212. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 213. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 214. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 215. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 216. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 217. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 218. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 219. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 220. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 221. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 222. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 223. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 231. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 232. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 233. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 234. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 235. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 236. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 237. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 238. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 239. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 240. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 241. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 242. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 243. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 244. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 245. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 246. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 247. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 248. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 249. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 250. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 251. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 252. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 253. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 254. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 255. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 256. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 257. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 258. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 259. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 260. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 261. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 262. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 263. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 264. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 265. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 266. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 267. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 268. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 269. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 270. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 271. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 272. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 273. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 274. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 275. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 276. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 277. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 278. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 279. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 280. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 281. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 282. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 283. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 284. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 285. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 286. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 287. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 288. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 289. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 290. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 291. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 292. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 293. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 294. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 295. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 296. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 297. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 298. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 299. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 300. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 301. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 302. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 303. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 304. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 305. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 306. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 307. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 308. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 309. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 310. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 311. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 312. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2027 (USD MILLION)
TABLE 313. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 314. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 315. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 316. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 317. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 318. SOUTH AFRICA AUTOIMMUNE DI

Companies Mentioned

  • Abbott Laboratories
  • AESKU.GROUP GmbH & Co. KG
  • AstraZeneca PLC
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • Biogenuix Medsystems Private Limited
  • bioMerieux SA
  • EUROIMMUN Medical Laboratory Diagnostics AG
  • Exagen Inc.
  • F. Hoffmann-La Roche AG
  • Hemagen Diagnostics, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi S.A.
  • SD BioSensor Inc.
  • Siemens Healthineers AG
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Werfen Group

Methodology

Loading
LOADING...